Chief Medical Officer

LSD shows promise for reducing anxiety in drugmaker's midstage study

Ticker: Acid passes stress test; Trump appeals tariff case to Supreme Court

Mind Medicine announces publication of results from MM120 Phase 2b study

LSD can help reduce anxiety, new study finds

Associate Director, Biostatistics

MindMed is a clinical stage biopharmaceutical company focused on developing innovative treatments for brain health disorders. The Associate Director of Biostatistics will lead statistical support for clinical development and regulatory filings, ensuring high-quality statistical deliverables and collaboration with cross-functional teams.

Sign up with Google

Sign in with Google